TheEdgeResearch
Home / Stocks / USNU

U.S. NeuroSurgical Holdings, Inc. (USNU)

OTC Healthcare Medical - Care Facilities
$1.03 ▲ +3.50%
Market Cap
$22.2M
Sector
Healthcare
Industry
Medical - Care Facilities
Beta
0.50
52-Wk Range
0.515-1.94
CEO
Jeereddi Anjaneya Prasad
Country
US
Currency
USD

U.S. NeuroSurgical Holdings, Inc. operates in the Medical - Care Facilities industry of the Healthcare sector, headquartered in Ontario, MD, US. The stock last traded at $1.03, up 3.50% on the session, giving a market capitalisation of $22.2M. On trailing twelve-month figures it carries a trailing P/E of -2.52, a net margin of -201.5%. Its beta of 0.50 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-2.52
Price / Sales
4.42
Price / Book
21.39
EV / EBITDA
-29.15
Gross margin
10.6%
Operating margin
-117.8%
Net margin
-201.5%
Return on equity
—
Debt / equity
0.00
Current ratio
0.81
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
3
IPO date
2007-10-09
Headquarters
Ontario, MD, US
About U.S. NeuroSurgical Holdings, Inc.

U.S. NeuroSurgical Holdings, Inc. oversees and operates specialized facilities for stereotactic radiosurgery, leveraging gamma knife technology. This gamma knife system functions as a precise, non-invasive radiosurgical instrument, effectively treating brain tumors and various cerebral malformations. The company, which originated in 1993, maintains its principal office in Rockville, Maryland.

Comparable companies

U.S. NeuroSurgical Holdings, Inc. is most often compared with the following Healthcare names:

DIZTFEMMLFHDSLFHQDAKBBTFKMSTFPCHMRTNXFVILGFVNNYF
More research on USNU
USNU technical analysis USNU TheEdge Score Compare against peers
Open full interactive analysis & DCF →